Physician profile
Robert J Weiss
NPI 1053306654
$6,202.58
in general payments reported to CMS, 2019-2025
16 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,975 · 2020: $91.60 · 2021: $1,012 · 2022: $297 · 2023: $166 · 2024: $2,524 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,325 · Education: $1,000 · Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,325.21 |
| Education | $1,000.00 |
| Food and Beverage | $501.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,789.04 | 2019-2024 | |
| W. L. Gore & Associates, INC. | $1,132.78 | 2021-2022 | |
| Organogenesis INC. | $243.38 | 2022-2025 | Puraply Wound Matrix |
| Davol INC. | $212.99 | 2019-2024 | Phasix Mesh |
| Integra Lifesciences Corporation | $128.05 | 2019 | |
| Advanced Oxygen Therapy INC. | $121.12 | 2019 | |
| Abbvie INC. | $115.26 | 2023 | Dalvance |
| Acell, INC. | $103.96 | 2019 | |
| Aroa Biosurgery Incorporated | $102.65 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $51.60 | 2019-2021 | |
| Tela Bio, INC. | $51.17 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $50.43 | 2019-2024 | Stratafix |
| Smith+Nephew, INC. | $42.83 | 2020-2025 | Collagenase Santyl |
| Solta Medical, A Division of Bausch Health US, LLC | $25.98 | 2024 | Clear+Brilliant |
| Pacira Pharmaceuticals Incorporated | $16.66 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $14.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.